| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/03/1992 | CA2104394A1 Recombinant thrombin receptor and related pharmaceuticals |
| 09/03/1992 | CA2104104A1 Intestinal trefoil proteins |
| 09/03/1992 | CA2081352A1 Composition and method for immunostimulation in mammals |
| 09/02/1992 | WO1992015695A1 Process for the c-terminal modification of peptides having a c_terminal penultimate proline residue |
| 09/02/1992 | WO1992015679A1 Improved epitode displaying phage |
| 09/02/1992 | EP0501937A1 Use of human IGF-I |
| 09/02/1992 | EP0501882A2 Method of anti LHRH immunoneutralization of non-castrated male animals and peptide therefore |
| 09/02/1992 | EP0501821A2 Anti-thrombin polypeptides |
| 09/02/1992 | EP0501641A1 L-2-oxothiazolidine-4-carboxylate and glutathion esters for the treatment of hepatic diseases |
| 09/02/1992 | EP0501637A2 Use of L-2-oxothiazolidine-4-carboxylate alone or in combination with glutathione esters and/or amino acids in the treatment of reperfusion injury |
| 09/02/1992 | EP0501445A1 Pharmaceutical composition comprising interleukin-2 |
| 09/02/1992 | EP0501354A1 Anticataract composition |
| 09/02/1992 | EP0501321A1 Immunosuppressive drug containing an anti-estradiol antibody |
| 09/02/1992 | EP0501320A1 Immunopotentiating drug containing an anti-testosterone antibody |
| 09/02/1992 | EP0501280A2 Renin-inhibiting peptide analogues |
| 09/02/1992 | EP0501250A1 Fucose-marked batracylin derivatives |
| 09/02/1992 | EP0501233A1 Hybridomas and monoclonal antibodies that inhibit anti-CD3-stimulated T cell proliferation |
| 09/02/1992 | EP0501215A2 Fusion proteins with monoclonal antibody, Linker and beta Glucuronidase for prodrug activation; preparation and use thereof |
| 09/02/1992 | EP0500989A1 N-(alpha-substituted-pyridinyl) carbonyl dipeptide antihypertensive agents |
| 09/02/1992 | EP0500921A1 Na-k-atpase inhibiting natriuretic substances |
| 09/02/1992 | EP0500901A1 Pharmaceutical compositions for use in treating parkinson's disease. |
| 09/02/1992 | EP0500893A1 Preservation of blood, tissues and biological fluids |
| 09/02/1992 | EP0500826A1 Apo ai polypeptides, antibodies, and immunoassays |
| 09/02/1992 | EP0500785A1 A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor |
| 09/02/1992 | EP0500773A1 Non-glycosylated fgf-4 and compositions containing the same |
| 09/02/1992 | EP0500745A1 Metal-peptide compositions and cosmetic methods for stimulating hair growth |
| 09/02/1992 | EP0500734A1 Protein complexes having factor viii:c activity and production thereof |
| 09/02/1992 | EP0500695A1 GnRH ANALOGS |
| 09/02/1992 | EP0500589A1 Purified protein and bioactive pharmaceutical. |
| 09/02/1992 | EP0493418A4 Method of producing fusion proteins |
| 09/02/1992 | CN1064080A Peptide compounds, process for preparation thereof and pharmaceutical composition comprising same |
| 09/02/1992 | CN1064018A Processes for preparation of compositions used in treatment of cell generation disorders |
| 09/02/1992 | CA2105303A1 Display phage |
| 09/02/1992 | CA2101074A1 Process for the c-terminal modification of peptides having a c-terminal penultimate proline residue |
| 09/02/1992 | CA2062065A1 Peptide analogues |
| 09/01/1992 | US5144019 Ribozyme cleavage of HIV-I RNA |
| 09/01/1992 | US5143906 Kedarcidin antitumor chromophore and pharmaceutical composition containing same |
| 09/01/1992 | US5143903 Method of treatment with tripeptide pharmaceutical compositions as immunomodulators |
| 09/01/1992 | US5143902 Glucagon analogs with ASP9 replacements or deletions |
| 09/01/1992 | US5143901 Preparation for treating and preventing thromboses and thromboembolic complications, use of such a preparation and a method of producing the same |
| 09/01/1992 | US5143843 Method for production of monoclonal antibodies for cancer diagnosis and therapy |
| 09/01/1992 | US5143836 Plasmids for expression of human superoxide dismutase (SOD) analogs containing lambda pl promoter with engineered restriction site for substituting ribosomal binding sites and methods of use thereof |
| 09/01/1992 | US5143829 One of the alanine residues following N-terminal methionine is removed |
| 09/01/1992 | US5143727 Method for preventing diarrhea |
| 09/01/1992 | CA1307076C DERIVATIVES OF THE N.alpha.-ARYLSULPHONYLAMINOACYL-P- AMIDINOPHENYLALANINAMIDES, THEIR PREPARATION PROCESS, THEIR USE AS MEDICAMENTS AND THE INTERMEDIATES FOR THEIR SYNTHESIS |
| 09/01/1992 | CA1306946C Specific antibody-containing substance from eggs and method of production and use thereof |
| 08/29/1992 | CA2061920A1 Anti-thrombin polypeptides |
| 08/28/1992 | WO1992015608A1 N-(α-SUBSTITUTED-PYRIDINYL)CARBONYL DIPEPTIDE ANTIHYPERTENSIVE AGENTS |
| 08/28/1992 | WO1992015289A1 Compositions and methods for topical administration of pharmaceutically active agents |
| 08/28/1992 | CA2081471A1 N-(ó-substituted-pyridinyl) carbonyl dipeptide antihypertensive agents |
| 08/28/1992 | CA2061993A1 Fucose-bearing cytostatics |
| 08/28/1992 | CA2061918A1 Pharmaceutical compositions comprising a lymphokine |
| 08/28/1992 | CA2061133A1 Anticataract composition |
| 08/27/1992 | WO1992014756A1 Therapeutically useful peptides and peptides fragments |
| 08/27/1992 | CA2061406A1 Immunosuppressive drug |
| 08/27/1992 | CA2061405A1 Immunopotentiating drug |
| 08/27/1992 | CA2061271A1 Method for the treatment of hepatic failure and disease |
| 08/27/1992 | CA2060746A1 Manufacture of calcium hydrosilicate bound fiberboard |
| 08/27/1992 | CA2059824A1 Hybridomas and monoclonal antibodies that inhibit anti-cd3-stimulated t cell proliferation |
| 08/26/1992 | EP0500387A2 Methods and compositions for the treatment of infection and control of flora using haloperoxidase |
| 08/26/1992 | EP0500170A2 Cyclic hexapeptides having antibiotic activity |
| 08/26/1992 | EP0500143A2 Pharmaceutical composition comprising an aminoglycoside phosphate |
| 08/26/1992 | EP0500003A2 Topical use of calcitonin for the preparation of medications in senile idiopathic cataract and a pharmaceutical composition thereof |
| 08/26/1992 | EP0499831A2 Combination of active agents comprising a sydnonimin derivate and a hirudin |
| 08/26/1992 | EP0499681A1 PCTD plasmid isolated form chlamydia trachomatis serotype D, its genes and proteins encoded by them; recombinant plasmids for the expression of said genes in heterologous systems as fused recombinant proteins, preparation of said recombinant proteins and their use in the formulation of vaccins and/or gianostics |
| 08/26/1992 | EP0499679A1 Therapeutic agent for diabetic gangrene |
| 08/26/1992 | EP0499625A1 Conglutinin fragments, their production and use |
| 08/26/1992 | EP0483219A4 Enhancement of musculature in animals |
| 08/26/1992 | EP0246322B1 Treatment of aids-type disease |
| 08/26/1992 | CA2037345A1 Endothelial cell-monocyte adhesion molecule |
| 08/25/1992 | US5142056 Human immunodeficiency virus protease inhibitor |
| 08/25/1992 | US5142032 Human papillomavirus type 41 dna |
| 08/25/1992 | US5141958 Inhibition of cell adhesion for reducing cancer cell metastases |
| 08/25/1992 | US5141947 Fibrinolysis-enhancing agents |
| 08/25/1992 | US5141925 Vivo methods for treating coccidiosis |
| 08/25/1992 | US5141924 Synthetic vasoactive intestinal peptide analogs |
| 08/25/1992 | US5141923 Methods for the treatment of retroviral infections |
| 08/25/1992 | US5141905 Bone morphogenic proteins induce bone and/or cartilage formation |
| 08/25/1992 | US5141863 Purification procedure of TPA from crude preparations |
| 08/25/1992 | US5141856 Expression of purified ciliary neurotrophic factor |
| 08/25/1992 | US5141851 Isolated farnesyl protein transferase enzyme |
| 08/25/1992 | US5141747 Denatured collagen membrane |
| 08/25/1992 | US5141736 Bispecific monoclonal antibody, its production and use |
| 08/25/1992 | CA1306707C Anti-human pulmonary adenocarcinoma specific monoclonal antibody |
| 08/25/1992 | CA1306690C Preparations active against pseudomonas aeruginosa infections and methods of producing them |
| 08/25/1992 | CA1306683C Methods and compositions for preventing ulcers |
| 08/23/1992 | WO1992014696A2 SUBSTITUTED α-AMINOALDEHYDES AND DERIVATIVES |
| 08/23/1992 | WO1992014482A1 Treatment of endotoxemia |
| 08/23/1992 | WO1992014480A1 Use of gm-csf and g-csf to promote accelerated wound healing |
| 08/23/1992 | CA2104602A1 Substituted .alpha.-aminoaldehydes and derivatives |
| 08/23/1992 | CA2104217A1 Treatment of endotoxemia |
| 08/23/1992 | CA2081104A1 Use of gm-csf and g-csf to promote accelerated wound healing |
| 08/21/1992 | CA2061488A1 Combination of active substances comprising a sydnone imine and a hirudin |
| 08/20/1992 | WO1992014483A1 Production and use of butyrylcholinesterase |
| 08/20/1992 | WO1992014155A1 Monoclonal antibodies directed towards mycobacterial antigens |
| 08/20/1992 | WO1992014150A1 Monoclonal antibodies against receptor-induced binding sites |
| 08/20/1992 | WO1992013958A1 Receptor blocking peptides of fibroblast growth factor receptor |
| 08/20/1992 | WO1992013955A1 Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
| 08/20/1992 | WO1992013952A1 Improved inhibitors of thrombin |
| 08/20/1992 | WO1992013950A2 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF β CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |